Jennifer Doudna
Biochemist and CRISPR pioneer. Follow the decisions, organizations and external forces shaping their influence.
What’s moving now
Current reporting about the person, the decisions and the organizations around them.
The part of CRISPR that keeps scientists up at night
The finding matters only as far as its evidence, limitations and independent verification can carry it.
Watch next: methodology, replication and disclosed uncertainty.Doudna Lab's 'Viper' Discovery Offers a Nuclease-Free, Reversible DNA Silencer
The development can change how institutions, businesses and households respond to Jennifer Doudna.
Watch next: verified adoption, measurable impact and confirmation from primary sources.Anthropic says Claude discovered novel enzyme system
The development can change how institutions, businesses and households respond to Jennifer Doudna.
Watch next: verified adoption, measurable impact and confirmation from primary sources.Endpoints 11: Azalea Therapeutics melds gene editing and CAR-T
The development can change how institutions, businesses and households respond to Jennifer Doudna.
Watch next: verified adoption, measurable impact and confirmation from primary sources.Anthropic's 950 Claude agents found an enzyme system in 21 hours, and nobody knows what it does
The development can change how institutions, businesses and households respond to Jennifer Doudna.
Watch next: verified adoption, measurable impact and confirmation from primary sources.From a girl who found a book to winning a Nobel Prize: Jennifer Doudna's mindset of "obsession"
The development can change how institutions, businesses and households respond to Jennifer Doudna.
Watch next: verified adoption, measurable impact and confirmation from primary sources.Scientists find an ancient predecessor of CRISPR hiding in viruses
The finding matters only as far as its evidence, limitations and independent verification can carry it.
Watch next: methodology, replication and disclosed uncertainty.AI model Claude discovers CRISPR-like enzyme system, Anthropic says
The development can change how institutions, businesses and households respond to Jennifer Doudna.
Watch next: verified adoption, measurable impact and confirmation from primary sources.Gene editing stocks fall after Anthropic’s CRISPR-like discovery
The market is repricing the expected growth, risk and capital flows connected to Jennifer Doudna.
Watch next: liquidity, breadth and whether the move survives the next data point.Jennifer Doudna’s journey from Hawaii puzzles to Nobel Prize-winning CRISPR research
The finding matters only as far as its evidence, limitations and independent verification can carry it.
Watch next: methodology, replication and disclosed uncertainty.Before CRISPR, there might have been VIPR. It could be a new gene-editing tool
The development can change how institutions, businesses and households respond to Jennifer Doudna.
Watch next: verified adoption, measurable impact and confirmation from primary sources.Jennifer Doudna receives National Medal of Technology and Innovation
The development can change how institutions, businesses and households respond to Jennifer Doudna.
Watch next: verified adoption, measurable impact and confirmation from primary sources.